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Background/Aims: Atrial arrhythmia (AA) occasionally occurs after lung trans-
plantation (LT); however, risk factors for AA and their impact on clinical outcomes 
are inconsistent. We aimed to investigate the incidence, predisposing factors, and 
clinical outcomes of AA after LT. 
Methods: We retrospectively evaluated 153 consecutive patients who underwent 
LT between January 2010 and August 2016. An AA episode was defined as a docu-
mented atrial fibrillation (AF), atrial flutter, or atrial tachycardia on 12-lead elec-
trocardiography or episodes lasting ≥ 30 seconds on telemetry monitoring. 
Results: The mean follow-up time was 22.0 ± 19.1 months. Postoperative AA oc-
curred in 46 patients (30.1%) after LT. Patients with postoperative AA were older, 
had larger body surface area, and had an increased incidence of paroxysmal AF 
prior to transplantation, idiopathic pulmonary fibrosis, and postoperative trache-
ostomy than patients without AA. Preoperative right atrial pressure (RAP) (odds 
ratio [OR], 1.19; p = 0.005) and longer periods of mechanical ventilation (OR, 1.03; 
p = 0.008) were found to be independent risk factors for AA after surgery. Devel-
opment of AA was a significant predictor of long-term overall mortality (hazard 
ratio, 2.75; p = 0.017). 
Conclusions: Patients with elevated preoperative RAP and long-term ventilator 
care had a higher risk of AA after LT. Further, AA after LT was associated with 
poor long-term survival.
Keywords: Lung transplantation; Atrial fibrillation; Atrial f lutter; Tachycardia, 
ectopic atrial; Survival
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INTRODUCTION
Lung transplantation (LT) has been 
performed increasingly over the past 
2 decades [1,2]. Atrial arrhythmias (AA), 
including atrial fibrillation (AF), atrial 
flutter (AFL), and atrial tachycardia (AT), 
are highly prevalent complications after 
LT, with a reported incidence ranging 
from 25% to 45% depending on their 
definition and methods of detection 
[3-9]. At present, there is inconsistent 
evidence supporting the association 
between mortality after LT and post-
operative AA [3,6,10,11]. In addition, dif-
ferent risk factors have been reported 
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with inconsistent results [3,7,11]. An increasing number 
of LT recipients at an advanced age, bilateral nature 
of LT, development of donor selection criteria, donor 
management protocols, and postoperative management 
are some current noteworthy changes, especially after 
the implementation of the lung allocation score in 2005 
[1,12], which necessitated re-evaluation of these arrhyth-
mias. Therefore, the purpose of this study was to assess 
the incidence of AA in patients who underwent LT and 
to determine its risk factors and impact on clinical out-
comes in the contemporary era.
METHODS
Patient population
This was a single-centered, retrospective cohort analy-
sis. The study was approved by the Institutional Review 
Board of Severance Hospital (IRB number: 2013-0522-
035) and was conducted in compliance with the Declara-
tion of Helsinki. Informed consent and a critical event 
committee were exempted by the board due to this 
study’s retrospective design. Lung transplant patients, 
who underwent either single or bilateral LT, between 
January 2010 and August 2016, were eligible for the 
study. Patients who underwent heart-lung transplanta-
tion or were lost to follow-up were excluded from this 
study. 
Data collection 
Baseline characteristics, operative and postoperative 
clinical variables, and clinical outcomes during the fol-
low-up period were captured from electronic medical 
records. Baseline demographics collected included: age, 
gender, comorbidities, history of AF, preoperative med-
ications, indications for LT, electrocardiography (ECG), 
echocardiographic data, right heart catheterization data 
(if available), and laboratory results. Operation notes 
were reviewed to obtain details of the surgery such as 
transplant type (single or bilateral), surgical procedure, 
and intraoperative complications. Preoperative echocar-
diographic data included left ventricular ejection frac-
tion (LVEF), size of the cardiac chambers, right atrial 
pressure (RAP), right ventricular systolic pressure, and 
E/E’ ratio. LVEF and left atrial volume were determined 
using the biplane Simpson’s method. RAP was estimat-
ed by evaluating the inferior vena cava during respira-
tion. Right ventricular systolic pressure was calculated 
by adding the estimated RAP to the pressure gradient 
between the right atrium and right ventricle (4 × peak 
tricuspid regurgitant jet velocity2). Further, to determine 
if postoperative clinical features predicted postopera-
tive AA, data on the duration of mechanical ventilation 
needed and cardiac markers were collected as well.
Study outcomes
All patients completed continuous ECG monitoring in 
the surgical intensive care unit (ICU). The outcomes 
collected included development of AA (including early 
and late postoperative AA), postoperative length of ICU 
stay, length of hospital stay, postoperative occurrences 
of stroke, and all-cause mortality. Early postoperative 
AA was defined as the first documentation of AF, AFL, 
or AT lasting ≥ 30 seconds via either a 12-lead ECG or 
rhythm strips obtained from the ECG monitoring with-
in 30 days of transplantation. Late AA was defined as the 
occurrence of AA, after 30 days of transplantation, at any 
time during the follow-up period. ECGs were analyzed 
by two independent cardiologists (B.G.K. and J.S.U.). 
Progress notes, emergency room records, and consul-
tation notes were also intensively reviewed to determine 
the physician’s assessment of arrhythmia or tachycardia. 
Onset time of postoperative AA was defined as the num-
ber of days from the date of LT to the date of the first ep-
isode of AA. Lengths of ICU stay and hospital stay were 
calculated from the date of LT to the date of transfer 
to the general ward and discharge, respectively. Postop-
erative occurrence of stroke was defined as occurrence 
of a focal neurological deficit confirmed from abnormal 
findings of brain imaging studies by a neurologist after 
surgery. All-cause mortality included any death after LT. 
Treatment strategies for AA episodes were stratified into 
rate control (β-blockers, non-dihydropyridine calcium 
channel blockers, and digoxin) and rhythm control (an-
ti-arrhythmic drugs and electrical cardioversion). Deci-
sions regarding treatments were at the discretion of the 
transplant surgeons or consulting cardiologists.
Statistical analysis
Continuous variables were presented as mean ± stan-
dard deviation and categorical variables were presented 
as number and percentage. Mean differences between 
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groups were tested using the Student’s t test for nor-
mally distributed data or the Mann-Whitney U test for 
skewed data. Categorical variables were analyzed us-
ing the Pearson’s chi-square test or Fisher’s exact test. 
Uni- and multivariate analyses using logistic regression 
models were constructed to validate predictors of AA. 
Variables with p < 0.1 from the univariate analyses were 
considered as potential risk factors of postoperative AA 
in the multivariate analyses. Log-rank and Kaplan-Mei-
er tests were used to compare survival between groups. 
Multivariate analysis using Cox proportional hazards 
models was performed to identify whether postopera-
tive AA development was one of the independent risk 
factors for mortality. All statistical analyses were carried 
out in SPSS version 23.0 (IBM Corp., Armonk, NY, USA). 
All tests were two-sided, and the results were considered 
statistically significant at p < 0.05.
RESULTS
Patient demographics
In total, 153 patients (age, 51.2 ± 13.6 years; men, 58.8%) 
who underwent LT were evaluated. Bilateral and single 
LT was performed in 141 (92.2%) and 12 (7.8%) patients, 
respectively. The major indications for LT were (in or-
der of frequency) idiopathic pulmonary fibrosis (IPF), 
graft-versus-host disease after hematopoietic stem cell 
transplantation, lymphangioleiomyomatosis, bronchi-
ectasis, and chronic obstructive pulmonary disease. Less 
frequent diagnoses included idiopathic pulmonary hy-
pertension, miliary tuberculosis, pulmonary capillary 
hemangioma, Langerhans cell histiocytosis, and inter-
stitial lung diseases associated with systemic rheumatic 
diseases. Comorbidities of the patients included hyper-
tension (20.9%), diabetes (17.6%), dyslipidemia (9.8%), 
and coronary artery disease (7.2%). All patients had sinus 
rhythm at the time of surgery, but five patients (3.3%) 
had a history of paroxysmal AF prior to the transplant. 
All patients were treated with standard immunosup-
pressive medications, such as tacrolimus, azathioprine, 
and prednisolone, after surgery.
Incidence, timing, and types of AA
The mean follow-up period post-transplantation was 
22.0 ± 19.1 months. During the follow-up period, AA de-
veloped in 46 of the 153 of patients (30.1%). Early post-
operative AA occurred in 40 patients (26.1%) with AA, of 
whom 26 (17.0%) had AF, 11 (7.2%) had AFL, and three 
(2.0%) had AT. There were no significant differences in 
the onset time among patients with AF, AFL, and AT (7.2 
± 5.3, 11.3 ± 6.9, and 17.3 ± 10.3 days, respectively; p = 0.195). 
The occurrence of early postoperative AA peaked on the 
postoperative day (POD) 4. In 67.5% of patients, AA de-
veloped within POD 10, and in 90.0% of patients before 
POD 20 (Fig. 1). The conversion of AA into sinus rhythm 
was observed in all patients during hospitalization and 
the mean duration of early postoperative AA was 2.6 ± 
2.6 days (range, 1 to 11). Late AA occurred in 11 patients 
(7.2%), of whom one (0.7%) had AF, two (1.3%) had AFL, 
and eight (5.2%) had AT. The median interval from LT 
to onset of late AA was 64 days (interquartile range, 45 
to 95). AF and AT were the most common AA in early 
and late postoperative periods (65.0% and 72.7%, respec-
tively) (Fig. 1). Conversion of late AA into sinus rhythm 
was also observed in all patients with a duration of 8.2 
± 10.4 days (range, 1 to 32). Five patients developed both 
early postoperative and late AA: three patients with early 
AF and one patient with early AFL developed AT: one 
patient with early AF developed AFL in the late postop-
erative period (Fig. 2) [13]. 
Risk factors for AA
Differences in patients’ characteristics according to the 
development of AA are presented in Table 1. Patients 
with AA were significantly older, had larger body sur-
face area (BSA), and had frequent incidences of AF be-
fore transplantion, IPF, and postoperative tracheostomy 
Figure 1. Incidence and time to onset of atrial arrhythmias 
after lung transplantation. AF, atrial fibrillation; AFL, atrial 
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than those without AA. No significant differences were 
observed between patients with and those without AA in 
preoperative echocardiographic data (including LVEF, 
left atrial size, RAP, right ventricular systolic pressure, 
and E/E’), and cardiac catheterization data (including 
mean pulmonary artery pressure, mean right atrial pres-
sure, and mean pulmonary capillary wedge pressure). 
Predictors of AA at any time after LT are shown in Table 
2. Longer periods of mechanical ventilation (hazard ra-
tio [HR], 1.03; 95% confidence interval [CI], 1.01 to 1.06; p 
= 0.008) and preoperative RAP (HR, 1.19; 95% CI, 1.06 to 
1.35; p = 0.005) were found to be significant risk factors 
for AA after LT, when adjusted for other risk factors.
Treatment strategies for AA
Forty of the 46 patients (87.0%) received treatment for 
AA. The remaining six patients, with early postoperative 
AA (three AF, one AFL, and two AT), were not treated as 
their heart rates remained stable and the AA was spon-
taneously converted to sinus rhythm within 1.8 ± 1.5 
days. Rate control treatment, using β-blockers, calcium 
channel blockers (diltiazem or verapamil), and digoxin, 
was used in the majority of patients (39 of 40, 97.5%). Six 
of the 40 patients (16.7%) were treated with combined 
antiarrhythmic medical therapy (amiodarone), and two 
patients underwent electrical cardioversion due to he-
modynamic instability. Non-vitamin K-dependent oral 
anticoagulants were administered to five patients with 
an AF lasting for > 2 days and a CHA2DS2-VASc score ≥ 2.
Clinical impact of AA
Length of ICU stay and hospital stay, as well as in-hos-
pital mortality, were not significantly different between 
patients with and without AA (Table 1). Stroke developed 
in six patients (3.9%) after LT, and the incidence was sim-
ilar between patients with and without AA. Long-term 
overall mortality was significantly higher in patients 
who developed AA in comparison to their counterparts 
(Fig. 3). Landmark analyses were performed to evaluate 
survival 30 days after LT. Incidence of all-cause mortali-
ty was higher in the patients with early postoperative AA 
than in those without AA (Fig. 4). Further, patients who 
developed late AA or both early and late AA had greater 
rate of all-cause mortality than those without AA. (Fig. 4).
The major causes of death in all LT recipients includ-
ed infection (63.0%) and multi-organ failure syndrome 
(16.1%). There was no difference in causes of death 
between the patients with and without AA (infection: 
64.0% vs. 62.1%, p = 0.872; multi-organ failure syndrome: 
16.0% vs. 13.8%, p = 0.826). All-cause mortality and cause 
of death were summarized in Table 3.
Postoperative AA, including early and late AA, was 
found to be an independent predictor of overall mor-
tality, even after adjustment for other covariates. An E/E’ 
> 15 and longer periods of mechanical ventilation were 
also identified as independent risk factors associated 
with increased mortality after LT (Table 4).
DISCUSSION
The major findings of this study were as follows: (1) AA 
was common after LT; (2) elevated preoperative RAP and 
long-term ventilator care were independent predictors 
for the development of AA after LT; and (3) all-cause 
Figure 2. A case of a 62-year-old man who was treated for 
atrial tachycardia with radiofrequency catheter ablation. (A) 
Electrocardiography showing atrial tachycardia. (B) Three-di-
mensional activation map reveals figure-of-eight intra-atrial 
reentrant tachycardia (white arrows) with the slow conduction 
zone at the anastomosis line. (C) Radiofrequency catheter 
ablation was performed along the ridge (red balls). Adaptad 
from Uhm et al. [13]. aVR, augmented Vector right; aVL, aug-
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Table 1. Baseline characteristics of patients with and without postoperative atrial arrhythmia
Characteristic AA (n = 46) No AA (n = 107) p value
Age at transplant, yr 57.0 ± 10.7 48.8 ± 14.0 < 0.001
Male sex 32 (69.6) 58 (54.2) 0.077
Body surface area, m2 1.65 ± 0.19 1.56 ± 0.24 0.042
Body mass index, kg/m2 21.7 ± 4.3 20.9 ± 3.7 0.275
Comorbidities
Hypertension 12 (26.1) 20 (18.7) 0.302
Diabetes 12 (26.1) 15 (14.0) 0.073
Dyslipidemia 7 (15.2) 8 (7.5) 0.149
Smoking 22 (47.9) 41 (38.3) 0.273
Coronary artery disease 6 (13.0) 5 (4.7) 0.088
Stroke 1 (2.2) 1 (0.9) 0.512
Atrial fibrillation 4 (8.7) 1 (0.9) 0.029
Serum creatinine, mg/dL 0.7 ± 0.3 0.7 ± 0.4 0.336
Indication for transplant
Idiopathic pulmonary fibrosis 34 (73.9) 56 (52.8) 0.015
GVHD 3 (6.5) 10 (9.4) 0.755
COPD 3 (6.5) 4 (3.8) 0.433
Bronchiectasis 2 (4.3) 5 (4.7) 0.921
Lymphangioleiomyomatosis 1 (2.2) 8 (7.5) 0.278
Other 3 (6.5) 23 (21.5) 0.024
Type of lung transplantation
Bilateral 43 (93.5) 98 (91.6) 0.487
Echocardiography findings
Ejection fraction, % 64.3 ± 9.8 64.3 ± 11.4 0.981
Left atrial volume index, mL/m2 19.1 ± 7.2 18.0 ± 7.2 0.596
RAP, mmHg 8.7 ± 5.2 7.2 ± 3.9 0.075
RVSP, mmHg 53.6 ± 27.6 49.2 ± 21.6 0.332
E/E’ 10.6 ± 4.5 10.5 ± 4.1 0.889
Right-sided heart catheterization data 
Mean PAP, mmHg 29.1 ± 14.4 28.2 ± 10.4 0.752
Mean RAP, mmHg 6.8 ± 3.7 8.0 ± 5.0 0.275
Mean PCWP, mmHg 10.8 ± 5.3 11.2 ± 6.7 0.756
Pre- and postoperative data
Preoperative PCPS 10 (22.2) 22 (20.8) 0.840
Preoperative MV 16 (35.6) 30 (28.3) 0.376
Postoperative TnT 0.810 ± 0.891 0.491 ± 0.264 0.056
Postoperative tracheostomy 35 (76.1) 45 (42.5) < 0.001
Perioperative MV duration, day 27.2 ± 20.5 17.8 ± 21.8 0.020
Length of postoperative ICU stay, day 14.5 ± 10.0 13.1 ± 12.1 0.541
Length of hospital stay, day 63.5 ± 55.1 47.8 ± 37.3 0.085
In-hospital mortality 4 (8.7) 5 (4.7) 0.242
New onset of stroke 3 (6.5) 3 (2.8) 0.360
Values are presented as mean ± SD or number (%).
AA, atrial arrhythmia; GVHD, graft-versus-host disease; COPD, chronic obstructive pulmonary disease; RAP; right atrial 
pressure; RVSP, right ventricular systolic pressure; PAP, pulmonary artery pressure; PCWP, pulmonary capillary wedge pres-
sure; PCPS, percutaneous cardiopulmonary support; MV, mechanical ventilation; TnT, troponin T; ICU, intensive care unit.
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mortality after LT was higher in patients with AA than 
in those without AA. 
Potential mechanisms of AA after LT 
Our data shows that AA occurred most frequently in 
the early postoperative period (within 30 days) and its 
frequency declined after 1 month. AF was the most 
commonly occurring AA in the early postoperative pe-
riod, whereas late AA was composed of mainly AT and 
AFL. These observations are consistent with previously 
reported data [4,5,14]. AF could be occurring frequent-
ly during the early postoperative period due to local 
inflammation, myocardial injury, sympathetic activa-
tion, fluid shift, and electrolyte imbalances [15-18]. Ad-
ditionally, the operative technique during LT, such as 
sutured anastomosis between the donor’s pulmonary 
Table 3. All-cause mortality and cause of death in patients 
with and without atrial arrhythmia
Variable AA (n = 46) No AA(n = 107) p value
30-day mortality 3 (6.5) 2 (1.9) 0.323
90-day mortality 8 (13.0) 11 (10.3) 0.780
1-yr mortality 23 (50.0) 25 (23.4) 0.001
All-cause mortality 25 (54.3) 29 (27.1) 0.001
Cause of death
Sepsis 16 (64.0) 18 (62.1)
Bleeding 3 (12.0) 4 (13.8)
Cardiac death 2 (8.0) 2 (6.9)
Multi-organ failure 4 (16.0) 4 (13.8)
Unknown 0 1 (3.4)
Values are presented as number (%).
AA, atrial arrhythmia.
Table 2. Uni- and multivariate analyses for predictors of postoperative atrial arrhythmia
Risk factor
Univariate analysis Multivariate analysis
OR (95% CI) p value OR (95% CI) p value
Age at transplant, /1 yr   1.05 (1.02–1.09) 0.002 0.97 (0.92–1.03) 0.327
Body surface area, /1 m2  8.35 (1.10–63.59) 0.040 3.09 (0.11–84.47) 0.504
History of atrial fibrillation 10.44 (1.13–96.18) 0.038 5.24 (0.39–71.11) 0.213
Idiopathic pulmonary fibrosis 2.41 (1.13–5.17) 0.024 2.30 (0.62–8.63) 0.216
RAP 1.09 (0.99–1.19) 0.060 1.19 (1.06–1.35) 0.005
MV duration, /1 day  1.03 (1.01–1.05) 0.004 1.03 (1.01–1.06) 0.008
OR, odds ratio; CI, confidence interval; RAP, right atrial pressure; MV, mechanical ventilation.
Figure 3. Kaplan-Meier curves for survival in patients with 




































Figure 4. Landmark analysis for survival after the first 30 
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vein cuffs and the recipient’s left atrium, can provide 
an electroanatomic substrate for potential AA [4,19]. 
However, it could also serve as an antral electrical iso-
lation of the pulmonary veins since the suture line is 
similar with the line ablation created by the Cox-Maze 
operation and can theoretically provide an antiar-
rhythmogenic effect for AF in the long-term. Later oc-
currences of AFL or AT than AF after LT could be due 
to reentry from the anastomosis after healing. Azadani 
et al. [14] reported a greater proportion of atypical pat-
tern of AFL in recipients who underwent LT and pro-
posed that atypical AFL stems from the suture line of 
the left atrium in contrast to typical AFL, which arises 
from the right atrium around the tricuspid annulus. 
In an electrophysiological study, See et al. [4] showed 
cases of postoperative AT related to macro-reentry that 
originated from suture lines, and focal AT that arose 
from the pulmonary vein anastomoses. Taken togeth-
er, these results suggest that surgical suture lines can 
help prevent AF, and can also act as substrate for the 
development of AFL or AT after scarring. Additional 
electrophysiological studies must be carried out to 
confirm this theory and better understand the mech-
anism of AA after LT. 
Risk factors for AA after LT 
In this study, we identified that elevated RAP and a 
prolonged period of mechanical ventilation period 
were independent predictors of AA, after adjusting 
for confounding variables. Mechanical ventilation in-
duces intermittent positive pressure during respirato-
ry cycles, which may raise intrathoracic pressure and 
right atrial pressure. Regardless, due to the application 
of additional positive end expiratory pressure, right 
atrial pressure may remain higher throughout the re-
spiratory cycle [20]. Such elevated right atrial pressure 
is related with occurrences of AA. Furthermore, pro-
longed periods of mechanical ventilation can cause an 
increase in sympathetic activity, which may trigger the 
development of AA.
Clinical significance of AA after LT 
Long-term all-cause mortality was significantly higher 
in patients with AA. Furthermore, the development of 
AA was identified as an independent predictor of over-
all mortality in the multivariate analysis. Interestingly, 
even though most AA occurred in the early postoper-
ative period, early clinical outcomes, such as length of 
ICU stay, length of hospital stay, and in-hospital mortal-
ity, were not different between patients with and with-
out AA in our study population. However, we clarified 
the prognostic impact of early postoperative AA on sur-
vival clearly in the long term via our landmark analysis. 
These findings are in agreement with the results re-
ported by Orrego et al. [3], which demonstrated a high-
er 12-month overall mortality in those who developed 
AA, but not at 90 days. Despite conflicting results of the 
impact of postoperative AA on long term survival after 
LT [11,21], a recent meta-analysis demonstrated that the 
occurrence of AA after LT has prognostic implications 
Table 4. Predictors for overall mortality after lung transplantation
Risk factor
Univariate analysis Multivariate analysis
HR (95% CI) p value HR (95% CI) p value
Age at transplant, /1 yr  1.02 (1.00–1.04) 0.071 1.00 (0.97–1.04) 0.894
Male sex 1.64 (0.93–2.89) 0.088 1.82 (0.75–4.39) 0.186
History of HTN 1.93 (1.08–3.43) 0.026 1.13 (0.46–2.77) 0.788
History of AF 7.17 (0.78–65.81) 0.082 0.79 (0.36–3.38) 0.646
E/E’ > 15  3.01 (1.44–6.31) 0.003 4.43 (1.55–12.70) 0.006
Preoperative PCPS 2.69 (1.51–4.81) 0.001 2.01 (0.49–8.20) 0.330
Preoperative mechanical ventilation 2.98 (1.73–5.14) < 0.001 1.09 (0.35–3.43) 0.883
MV duration, /1 day 1.04 (1.03–1.05) < 0.001 1.03 (1.01–1.05) < 0.001
Atrial arrhythmia after LT 2.49 (1.45–4.26) 0.001 2.75 (1.20–6.32) 0.017
HR, hazard ratio; CI, confidence interval; HTN, hypertension; AF, atrial fibrillation; PCPS, percutaneous cardiopulmonary 
support; MV, mechanical ventilation; LT, lung transplantation.
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for overall long-term survival [22]. Taken together, these 
results suggest that development of AA after LT may not 
influence short-term mortality, but likely affects over-
all long-term mortality. Moreover, we found that devel-
opment of late AA was also linked with poor long-term 
survival after LT. To our knowledge, an association be-
tween late AA after LT and survival has not been report-
ed in prior studies. In this study, we could not identify 
the differences in characteristics between patients with 
late AA and their counterparts due to a small sample 
size. Further large-scale studies need to be carried out 
to address this issue.
The mechanisms that drive postoperative AA and re-
sult in poor long-term survival are not known. Mean 
time to death after development of AA was 76.0 ± 78.5 
days in our study. Most patients died from infection, 
bleeding or multi-organ failure, and these poor med-
ical conditions could have acted as a trigger for AA. In 
addition, longer periods of perioperative mechanical 
ventilation, which was related to development of AA, 
may reflect the more complex surgery and complica-
tions like infection. Therefore, we speculate that AA 
may serve as a potential surrogate marker to identify 
unstable medical conditions that may make patients 
vulnerable to stress and may increase their risk of mor-
tality.
Study limitations
There are several limitations to be noted. Given the 
retrospective nature of this study at a single institu-
tion with a small number of patients, unmeasured con-
founders associated with AA such as consistent surgical 
techniques or postoperative care might have biased the 
results despite statistical adjustments. Further, some 
short and asymptomatic arrhythmic episodes during 
inconsistent ECG monitoring in the general ward or 
late AA events could have been missed. However, given 
complete access and review of these events, it is not 
likely that meaningful information was lost. Addition-
ally, we could not determine the mechanisms driving 
postoperative AA due to unavailable electrophysiolog-
ical data in our study. Further large-scale electrophys-
iological studies are required to better understand the 
mechanisms of AA and establish prevention strategies 
in LT recipients. 
In conclusion, patients with preoperative RAP and 
long-term ventilator care had a higher risk of develop-
ing AA after LT. Further, AA after LT is associated with 
poor long-term survival.
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